Stanford researchers developed a technology that efficiently identifies combinations of genetic interventions with lasting, effective therapeutic functions by constructing genetic perturbation libraries containing the desired combination of phenotypes extracted from each cell.
Researchers at Stanford have developed a robotic pill platform to collect biomarkers, which serve as indicators of disease, from specified body cavities over prolonged sampling periods.
Mechanical ventilation (MV) is a widely used treatment modality for the management of respiratory failure in intensive care units (ICU). An estimated 300,000 patients undergo MV annually in the U.S.
Researchers at Stanford have developed AgeIndex, the first whole-genome epigenetic aging index and method based on Whole Genome Bisulfite Sequencing (WGBS) assays.
Stanford researchers led by Dr. Arun Majumdar have developed photocatalysts combining transport- and reaction-selective nanostructures for direct methanol production.
Stanford researchers have developed a device that combines one-photon and two-photon microscopy using fast temporal multiplexing enabling 3D alignment between in vivo and ex vivo data for neuroscience and spatial biology applications.
Stanford scientists have developed a safe, minimally invasive catheter system that delivers acoustic energy to urethral stones and disintegrates them to treat renal colic.
Cancers including breast, lung, colon and prostate account for almost ten million deaths worldwide every year. The main cause of cancer deaths is metastasis, which is the propensity of cancer cells to spread throughout the body.
Stanford inventors have identified a treatment regimen that allows expansion of cardiomyocytes (CMs) derived from human induced pluripotent stem cells in vitro.
Stanford scientists have invented an implicit an Neural Representation learning methodology with Prior embedding (NeRP) to reconstruct a computational medical image from sparsely sampled measurements using only a prior image of the subject.